secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2026-10-13T20:01:25+00:00
Accession:  0001628280-26-065685
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Senti Bio adjourns annual meeting to Oct 15 to solicit votes for merger proposal
--------------------------------------------------------------------------------

- 2026 Annual Meeting convened virtually on Oct 8, 2026 and was adjourned without conducting any business even though a quorum was present.
- Adjournment is to gain more time to solicit votes in favor of the Merger Agreement Proposal described in the Sept 24, 2026 definitive proxy statement.
- Meeting reconvenes Thursday, Oct 15, 2026 at 8:00 a.m. Pacific at virtualshareholdermeeting.com/SNTI2026; no proposals changed and all polls stay open.
- Record date remains Sept 23, 2026; stockholders who already voted need take no action unless they want to change their vote.
- Filing gives no merger counterparty, deal terms or vote tally; SNTI common stock trades on the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026065685/0001628280-26-065685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026065685/snti-20261008.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-065685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer